US Bancorp’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$146K Sell
17,983
-1,773
-9% -$14.4K ﹤0.01% 2218
2025
Q1
$155K Buy
19,756
+12,869
+187% +$101K ﹤0.01% 2159
2024
Q4
$103K Buy
6,887
+6,615
+2,432% +$98.5K ﹤0.01% 2387
2024
Q3
$4.16K Sell
272
-1,790
-87% -$27.4K ﹤0.01% 3619
2024
Q2
$31.4K Buy
2,062
+1,353
+191% +$20.6K ﹤0.01% 2873
2024
Q1
$13.4K Sell
709
-7,952
-92% -$150K ﹤0.01% 3224
2023
Q4
$165K Buy
8,661
+6,751
+353% +$129K ﹤0.01% 2103
2023
Q3
$34.3K Sell
1,910
-1
-0.1% -$18 ﹤0.01% 2620
2023
Q2
$38.8K Buy
1,911
+536
+39% +$10.9K ﹤0.01% 2601
2023
Q1
$25.1K Buy
1,375
+328
+31% +$5.98K ﹤0.01% 2866
2022
Q4
$21.7K Buy
1,047
+547
+109% +$11.3K ﹤0.01% 2944
2022
Q3
$13K Buy
500
+31
+7% +$806 ﹤0.01% 3265
2022
Q2
$12K Sell
469
-99
-17% -$2.53K ﹤0.01% 3297
2022
Q1
$18K Buy
568
+277
+95% +$8.78K ﹤0.01% 3128
2021
Q4
$12K Sell
291
-252
-46% -$10.4K ﹤0.01% 3336
2021
Q3
$19K Buy
543
+444
+448% +$15.5K ﹤0.01% 3140
2021
Q2
$3K Hold
99
﹤0.01% 3731
2021
Q1
$3K Hold
99
﹤0.01% 3603
2020
Q4
$3K Buy
+99
New +$3K ﹤0.01% 3484
2020
Q3
Sell
-44
Closed -$1K 3733
2020
Q2
$1K Buy
+44
New +$1K ﹤0.01% 3556
2019
Q3
Sell
-2,891
Closed -$23K 3657
2019
Q2
$23K Hold
2,891
﹤0.01% 2825
2019
Q1
$36K Buy
2,891
+645
+29% +$8.03K ﹤0.01% 2637
2018
Q4
$25K Buy
2,246
+120
+6% +$1.34K ﹤0.01% 2730
2018
Q3
$30K Buy
+2,126
New +$30K ﹤0.01% 2784